Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1989 3
1990 2
1991 15
1992 20
1993 28
1994 36
1995 119
1996 89
1997 114
1998 121
1999 116
2000 118
2001 149
2002 179
2003 128
2004 133
2005 161
2006 116
2007 118
2008 116
2009 121
2010 125
2011 127
2012 110
2013 125
2014 108
2015 100
2016 108
2017 93
2018 95
2019 113
2020 100
2021 89
2022 105
2023 100
2024 91
2025 109
2026 75

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,502 results

Results by year

Filters applied: . Clear all
Page 1
Vonoprazan Versus Lansoprazole for Healing and Maintenance of Healing of Erosive Esophagitis: A Randomized Trial.
Laine L, DeVault K, Katz P, Mitev S, Lowe J, Hunt B, Spechler S. Laine L, et al. Gastroenterology. 2023 Jan;164(1):61-71. doi: 10.1053/j.gastro.2022.09.041. Epub 2022 Oct 10. Gastroenterology. 2023. PMID: 36228734 Free article. Clinical Trial.
METHODS: Adults with erosive esophagitis were randomized to once-daily vonoprazan, 20 mg, or lansoprazole, 30 mg, for up to 8 weeks. Patients with healing were rerandomized to once-daily vonoprazan, 10 mg, vonoprazan, 20 mg, or lansoprazole, 15 mg, for 24 weeks. ... …
METHODS: Adults with erosive esophagitis were randomized to once-daily vonoprazan, 20 mg, or lansoprazole, 30 mg, for up to 8 weeks. …
Lansoprazole (LPZ) reverses multidrug resistance (MDR) in cancer through impeding ATP-binding cassette (ABC) transporter-mediated chemotherapeutic drug efflux and lysosomal sequestration.
Ji N, Li H, Zhang Y, Li Y, Wang P, Chen X, Liu YN, Wang JQ, Yang Y, Chen ZS, Li Y, Wang R, Kong D. Ji N, et al. Drug Resist Updat. 2024 Sep;76:101100. doi: 10.1016/j.drup.2024.101100. Epub 2024 Jun 4. Drug Resist Updat. 2024. PMID: 38885537
AIMS: Lansoprazole is one of the many proton pump inhibitors (PPIs) that acts more strongly with ABCB1 and ABCG2. ...Western blot and immunofluorescence were used to detect lansoprazole on ABCB1/G2 expression and subcellular localization. MDR nude mice models were e …
AIMS: Lansoprazole is one of the many proton pump inhibitors (PPIs) that acts more strongly with ABCB1 and ABCG2. ...Western blot and …
Phase III, randomised, double-blind, multicentre study to evaluate the efficacy and safety of vonoprazan compared with lansoprazole in Asian patients with erosive oesophagitis.
Xiao Y, Zhang S, Dai N, Fei G, Goh KL, Chun HJ, Sheu BS, Chong CF, Funao N, Zhou W, Chen M. Xiao Y, et al. Gut. 2020 Feb;69(2):224-230. doi: 10.1136/gutjnl-2019-318365. Epub 2019 Aug 13. Gut. 2020. PMID: 31409606 Free PMC article. Clinical Trial.
OBJECTIVE: To establish the non-inferior efficacy of vonoprazan versus lansoprazole in the treatment of Asian patients with erosive oesophagitis (EO). DESIGN: In this phase III, double-blind, multicentre study, patients with endoscopically confirmed EO were randomised 1:1 …
OBJECTIVE: To establish the non-inferior efficacy of vonoprazan versus lansoprazole in the treatment of Asian patients with erosive o …
[Lansoprazole-induced gynecomastia].
Comas A, Salgueiro E, Hidalgo A. Comas A, et al. Med Clin (Barc). 2000 Mar 18;114(10):397. doi: 10.1016/s0025-7753(00)71307-8. Med Clin (Barc). 2000. PMID: 10786353 Spanish. No abstract available.
Lansoprazole-Induced Myoclonus.
Kumar RNK, Sharma VK. Kumar RNK, et al. Tremor Other Hyperkinet Mov (N Y). 2026 Aug 14;16:47. doi: 10.5334/tohm.1236. eCollection 2026. Tremor Other Hyperkinet Mov (N Y). 2026. PMID: 42602919 Free PMC article.
Although Lansoprazole, a proton pump inhibitor, is quite safe, there have been occasional reports of associated neurological dysfunction. We present a middle-aged man who developed bilateral asterixis within few hours of the first dose of lansoprazole. Interestingly …
Although Lansoprazole, a proton pump inhibitor, is quite safe, there have been occasional reports of associated neurological dysfunct …
Lansoprazole-induced thrombocytopenia.
Zlabek JA, Anderson CG. Zlabek JA, et al. Ann Pharmacother. 2002 May;36(5):809-11. doi: 10.1345/aph.1A303. Ann Pharmacother. 2002. PMID: 11978156
Lansoprazole was discontinued, and the platelet count returned to normal. He has not had any further episodes of thrombocytopenia to date. ...To date, this is the first reported case of what appears to be isolated thrombocytopenia associated with lansoprazole. CONCL …
Lansoprazole was discontinued, and the platelet count returned to normal. He has not had any further episodes of thrombocytopenia to …
[Proton-pump inhibitor use and hyponatremia].
Goto M, Sakai M. Goto M, et al. Nihon Ronen Igakkai Zasshi. 2023;60(2):153-157. doi: 10.3143/geriatrics.60.153. Nihon Ronen Igakkai Zasshi. 2023. PMID: 37225507 Free article. Japanese.
The PPI group was further divided into the lansoprazole group (LPZ group) and the other PPI group. Other PPI users were excluded due to small numbers. ...CONCLUSION: A higher rate of hyponatremia was induced in older residents of long-term care facilities who took lanso …
The PPI group was further divided into the lansoprazole group (LPZ group) and the other PPI group. Other PPI users were excluded due …
Concomitant use of lansoprazole and ceftriaxone is associated with an increased risk of ventricular arrhythmias and cardiac arrest in a large Japanese hospital database.
Mitsuboshi S, Imai S, Kizaki H, Hori S. Mitsuboshi S, et al. J Infect. 2024 Aug;89(2):106202. doi: 10.1016/j.jinf.2024.106202. Epub 2024 Jun 17. J Infect. 2024. PMID: 38897240 Free article.

RESULTS: The results showed that the risk of ventricular arrhythmia and cardiac arrest was significantly higher with concomitant ceftriaxone and oral lansoprazole (hazard ratio 2.92, 95% confidence interval 1.99-4.29, P < 0.01) or intravenous lansoprazole (hazard

…
RESULTS: The results showed that the risk of ventricular arrhythmia and cardiac arrest was significantly higher with concomitant ceftriaxone …
[Lansoprazol].
Ponce J, Nos P. Ponce J, et al. Gastroenterol Hepatol. 1995 Feb;18(2):101-9. Gastroenterol Hepatol. 1995. PMID: 7621274 Review. Spanish. No abstract available.
Intravenous lansoprazole: in erosive oesophagitis.
Dando TM, Plosker GL. Dando TM, et al. Drugs. 2004;64(18):2085-9; discussion 2090. doi: 10.2165/00003495-200464180-00008. Drugs. 2004. PMID: 15341501 Review.
An intravenous formulation of lansoprazole, a proton pump inhibitor, is approved for use in patients with erosive oesophagitis who are temporarily unable to take oral lansoprazole. ...Median pentagastrin-stimulated gastric acid output levels were equivalent after 7 …
An intravenous formulation of lansoprazole, a proton pump inhibitor, is approved for use in patients with erosive oesophagitis who ar …
3,502 results